Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6586 AL 6600

Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases

Varshney V, Gabble BC, Bishoyi AK, Varma P, Qahtan SA, Kashyap A, Panigrahi R, Nathiya D, Chauhan AS.

Mol Neurobiol. 2025 Nov;62(11):14683-14705. doi: 10.1007/s12035-025-05026-w. Epub 2025 May 10.

Neuroprotective mechanism of LincRNA in neurodegenerative diseases

Lin Y, Wang J, Liu B, Hu T, Gu J.

Gene. 2025 Oct 5;967:149722. doi: 10.1016/j.gene.2025.149722. Epub 2025 Aug 13.

Variation in the reported prevalence of Huntington's disease: a systematic review and guide to interpretation

Thompson A, Quarrell O, Strong M.

J Neurol. 2025 Jul 24;272(8):534. doi: 10.1007/s00415-025-13255-1.

Genetic and epigenetic drivers of neurodegenerative disorders

Roy K, Syed M, Narad P, Sengupta A.

Prog Brain Res. 2025;297:53-130. doi: 10.1016/bs.pbr.2025.08.002. Epub 2025 Oct 7.

Chloride Homeostasis in Neuronal Disorders: Bridging Measurement to Therapy

Arosio D, Musio C.

Life (Basel). 2025 Sep 17;15(9):1461. doi: 10.3390/life15091461.

Current perspectives on gene therapy and its involvement in curing genetic disorders

Nishad S, Dongare D, Saha S, Anil RD, Srivastava N, Dey A.

Hum Genet. 2025 Jul;144(7):695-713. doi: 10.1007/s00439-025-02757-7. Epub 2025 Jun 18.

Evaluation, Diagnosis, and Treatment of Sydenham Chorea: Consensus Guidelines

Thomas T, Eyre M, Ferrarin E, Newlove-Delgado T, Sie A, Armangue T, Ben-Pazi H, Benrhouma H, Clavenna A, Cardoso F, Dure LS, Jones HF, Gilbert DL, Gulati S, Jiang Y, Krajnc N, Mohammad SS, Orsini A, Sharma S, Swedo SE, Webb R, Wilmshurst JM, Yaramis A, Yilmaz S, Zuberi S, Morton M, Dale RC, Nosadini M, Lim M.

Pediatrics. 2025 Dec 1;156(6):e2025072466. doi: 10.1542/peds.2025-072466.

Retinal Neurovascular Coupling: From Mechanisms to a Diagnostic Window into Brain Disorders

Shen W.

Cells. 2025 Nov 16;14(22):1798. doi: 10.3390/cells14221798.

Mitochondrial DAMPs: Key mediators in neuroinflammation and neurodegenerative disease pathogenesis

Yu H, Ren K, Jin Y, Zhang L, Liu H, Huang Z, Zhang Z, Chen X, Yang Y, Wei Z.

Neuropharmacology. 2025 Feb 15;264:110217. doi: 10.1016/j.neuropharm.2024.110217. Epub 2024 Nov 16.

Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models

Xu R, Kang Q, Yang X, Yi P, Zhang R.

Int J Mol Sci. 2025 Mar 26;26(7):3030. doi: 10.3390/ijms26073030.

Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update

Wu WL, Gong XX, Qin ZH, Wang Y.

Acta Pharmacol Sin. 2025 Dec;46(12):3129-3142. doi: 10.1038/s41401-025-01576-w. Epub 2025 May 19.

Beyond Alzheimer's disease-translating biomarker insights across CNS diseases

Brady LS, Mahinrad S, Edelmayer RM, Potter WZ, Hutten SJ, Anticevic A, Taylor-Burds C, Winston CN, Coetzee T, Paulsen JS, Mantua V, Childers EP, Kolb HC, Jack CR Jr, Jagust WJ, Wagner JA, Sivakumaran S, Shaw L, Sharma VM.

Sci Transl Med. 2025 Nov 5;17(823):eadr2511. doi: 10.1126/scitranslmed.adr2511. Epub 2025 Nov 5.

Huntington's disease in MENAT: systematic review and meta-analysis of prevalence, clinical features, and genetics

Alshimemeri S, Shadid AM, Aldraihem O, Alsaber N.

J Neurol. 2025 Oct 14;272(10):693. doi: 10.1007/s00415-025-13453-x.

Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases

Duță C, Dogaru CB, Muscurel C, Stoian I.

Int J Mol Sci. 2025 Apr 9;26(8):3522. doi: 10.3390/ijms26083522.

Human Glucose Transporters in Health and Selected Neurodegenerative Diseases

Szablewski L.

Int J Mol Sci. 2025 Jul 31;26(15):7392. doi: 10.3390/ijms26157392.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias